# US 2021/0343367 A1 · Methods for detecting mutation load from a tumor sample

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0343367 A1
- Document ID: US20210343367A1
- Status: Published application
- Kind: A1
- Application number: 17/371,378
- Filed: 2021-07-09
- Published: 2021-11-04
- Earliest claimed: 2016-12-08
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: Ruchi Chaudhary; Fiona HYLAND
- Web page: https://patentgrep.com/patent/US20210343367A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 30/10: Sequence alignment; Homology search
- G16B 50/10: Ontologies; Annotations
- G16B 20/40: Population genetics; Linkage disequilibrium
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

A targeted panel with low sample input requirements from a tumor only sample may be processed to estimate mutation load in a tumor sample. The method may include detecting variants in nucleic acid sequence reads corresponding to targeted locations in the tumor sample genome; annotating detected variants with an annotation information from a population database; filtering the detected variants, wherein the filtering rule set retains the somatic variants and removes germ-line variants; counting the identified somatic variants to give a number of somatic variants; determining a number of bases in covered regions of the targeted locations in the tumor sample genome; and calculating a number of somatic variants per megabase, provides an estimate of the mutation load per megabase in the tumor sample genome.

## Claims

### Claim 1

A method of analyzing a tumor sample genome for a mutation load, comprising:
amplifying nucleic acid sequences at targeted locations in the tumor sample genome by a targeted panel with a low sample input from the tumor sample to generate a plurality of nucleic acid sequence reads, wherein the tumor sample is a tumor only sample;
detecting variants in the plurality of nucleic acid sequence reads to produce a plurality of detected variants;
filtering the plurality of detected variants, wherein the filtering applies a rule set to the detected variants to retain somatic variants;
calculating a tumor mutation load in the tumor only sample by dividing a number of the somatic variants by a number of bases in covered regions of the targeted locations.

### Claim 2 (depends on 1)

The method of claim 1, wherein the low sample input comprises 1 ng to 40 ng of sample DNA.

### Claim 3 (depends on 1)

The method of claim 1, wherein the low sample input comprises 1 ng to 20 ng of sample DNA.

### Claim 4 (depends on 1)

The method of claim 1, wherein the low sample input comprises 10 ng to 20 ng of sample DNA.

### Claim 5 (depends on 1)

The method of claim 1, wherein the targeted panel covers approximately 1.7 Mb of the tumor sample genome.

### Claim 6 (depends on 1)

The method of claim 1, further comprising annotating one or more detected variants of the plurality of detected variants with an annotation information from one or more population databases, wherein the population databases include information associated with variants in a population.

### Claim 7 (depends on 6)

The method of claim 6, wherein the annotation information includes a minor allele frequency associated with a given variant.

### Claim 8 (depends on 1)

The method of claim 1, wherein the rule set includes retaining the detected variants whose minor allele frequency (MAF) is within a MAF range.

### Claim 9 (depends on 8)

The method of claim 8, wherein the MAF range is from 0 to 10−6.

### Claim 10 (depends on 8)

The method of claim 8, wherein the MAF range is from 0 to 0.01.

### Claim 11 (depends on 1)

The method of claim 1, wherein the rule set further comprises retaining the detected variants that are single nucleotide variants (SNVs).

### Claim 12 (depends on 1)

The method of claim 1, wherein the rule set further comprises retaining the detected variants that are SNVs, insertion variants and deletion variants (indels).

### Claim 13 (depends on 1)

The method of claim 1, wherein the rule set further comprises removing the detected variants that are SNVs corresponding to SNPs in a UCSC Common SNP database.

### Claim 14 (depends on 1)

The method of claim 1, wherein the rule set further comprises removing the detected variants in regions having homopolymer lengths greater than seven.

### Claim 15 (depends on 1)

The method of claim 1, wherein the step of detecting variants is configured by a variant caller parameter including a minimum coverage parameter.

### Claim 16 (depends on 15)

The method of claim 15, wherein the minimum coverage parameter is in a range from 20 to 60.

### Claim 17 (depends on 1)

The method of claim 1, wherein the step of detecting variants is configured by a variant caller parameter including a minimum allele frequency parameter.

### Claim 18 (depends on 1)

The method of claim 1, wherein the step of detecting variants is configured by a variant caller parameter including a strand bias parameter.

### Claim 19 (depends on 1)

The method of claim 1, wherein the step of detecting variants is configured by a variant caller parameter including a data quality stringency parameter.

### Claim 20 (depends on 1)

The method of claim 1, further comprising associating sources of somatic mutation damage with the somatic variants.
